Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 149602
Author(s) Schwab, S. G.; Bagli, M.; Papassotiropoulos, A.; Jessen, F.; Maier, W.; Rao, M. L.; Heun, R.
Author(s) at UniBasel Papassotiropoulos, Andreas
Year 1999
Title Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population
Journal Dementia and Geriatric Cognitive Disorders
Volume 10
Number 6
Pages / Article-Number 469-72
Keywords alpha(1)-antichymotrypsin, apolipoprotein E, Alzheimer's disease, association
Abstract The A allele of a common A-T polymorphism in the signal peptide of alpha(1)-antichymotrypsin gene (ACT) has been reported to contribute a two- to threefold increased risk to Alzheimer's disease (AD) patients who carry the apolipoprotein E epsilon4 (APOE epsilon4) genotype. Since the ACT expression in AD brains is enhanced in particular in areas that develop amyloid plaques, the ACT polymorphism is considered to be a good candidate gene. We have analyzed this polymorphism in 102 AD patients and 191 matched controls, all originating from Western Germany. No statistically significant differences in allele frequencies and in genotype distribution of ACT could be shown between AD patients and controls. When we analyzed the polymorphism in APOE epsilon4 carriers, no overrepresentation in our AD group could be shown for the ACT*AA genotype carriers. Copyrightz1999S.KargerAG,Basel
Publisher Karger
ISSN/ISBN 1420-8008 ; 1421-9824
edoc-URL http://edoc.unibas.ch/dok/A5257224
Full Text on edoc Available
Digital Object Identifier DOI 10.1159/000017191
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/10559561
ISI-Number WOS:000083635000007
Document type (ISI) Clinical Trial, Journal Article
 
   

MCSS v5.8 PRO. 0.342 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
20/04/2024